ABRYSVO met its trial primary endpoints in adults aged 18 to 59 with an increased respiratory syncytial virus (RSV) disease risk.
The receipt of this permission paves way for the launch of BREZTRI AEROSPHERE in India
Accelerating FDA submission and confirming potential to become first approved biologic for this serious disease
Lupin Vilfuro-G is the only FDC that uniquely combines Vilanterol, Fluticasone Furoate and Glycopyrronium Bromide
The countrywide initiative aims to spread awareness, educate the public & ensure that no one is left behind in the fight against respiratory diseases
The initiative will focus on advocating for cleaner air
Education on Inhalation Therapy & Conducting Nationwide Awareness Camps, Alkem Breathe Initiative Addresses the Alarming Increase in Respiratory Diseases in India
This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US
Honeywell Solstice Air is a hydrofluoroolefin (HFO) propellant in clinical development today for pMDIs
Lupin actively contributes to alleviating the burden of COPD for patients across the nation
Subscribe To Our Newsletter & Stay Updated
